SCHEMBL2836574

SCHEMBL2836574

O=C(CSc1ccc2ccccc2c1)N1CCC(N2CCCC2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 7/20 0.58
MAPT P10636 2/20 0.58
KDM4E B2RXH2 1/20 0.58
GAA P10253 1/20 0.58
ATM Q13315 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
L3MBTL3 Q96JM7 5/20 0.52
ACHE P22303 1/20 0.49
TP53BP1 Q12888 2/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
RAB9A P51151 2/20 0.48
KMT2A Q03164 1/20 0.48
CBX7 O95931 2/20 0.47
CDYL2 Q8N8U2 2/20 0.47
CDYL Q9Y232 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
CDY1; CDY1B Q9Y6F8 1/20 0.47
CHRM2 P08172 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4378474 0.90 KDM4E (0.61) L3MBTL1MAPTKDM4EGAAATM
SCHEMBL4380926 0.89 KDM4E (0.60) L3MBTL1MAPTKDM4EGAAATM
SCHEMBL2833292 0.81 L3MBTL1 (0.58) L3MBTL1KDM4EGAAL3MBTL3TP53BP1
SCHEMBL2831262 0.78 NPC1 (0.76) MAPTKDM4EGAATDP1ACHE
SCHEMBL14218059 0.76 KMT2A (0.67) L3MBTL1MAPTKDM4EGAAATM
SCHEMBL2852216 0.74 ALDH1A1 (0.49) L3MBTL1MAPTKDM4ETDP1L3MBTL3
SCHEMBL4377257 0.73 RAB9A (0.75) L3MBTL1MAPTKDM4EGAAATM
SCHEMBL2852341 0.73 CYP1A2 (0.52) L3MBTL1KDM4EL3MBTL3ACHETP53BP1
SCHEMBL31323039 0.72 SMN1; SMN2 (0.66) L3MBTL1MAPTKDM4EATMTDP1
SCHEMBL4377583 0.72 MAPT (0.77) L3MBTL1MAPTKDM4EGAAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP claimed
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP disclosed
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP disclosed
US-7064135-B2 Substituted piperidines NOVO NORDISK INC. (DK) 2006-06-20 US disclosed